Technical analysis of None (GDTC): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
CytoMed Therapeutics Limited is a biopharmaceutical company in the pre-clinical development phase, founded in 2018 and based in Singapore. The firm specializes in creating advanced cellular immunotherapies aimed at combating various human malignancies.
Price Performance
| 1 month | -5.70% |
| 3 months | -17.96% |
| Year-to-date | -33.88% |
| 1 year | -52.87% |
| 3 years | -76.05% |
52-Week Range
| 52-week High | $3.68 |
| 52-week Low | $0.68 |
| Avg Volume (90d) | 63K |
Technical Indicators
| SMA 50 | $0.91 |
| SMA 200 | $1.08 |
| Beta | -0.21 |
| 30-day Volatility (annualised) | 87.5% |
| Price vs SMA 50 | -2.9% |
| Price vs SMA 200 | -17.7% |
Monthly Close (12 months)
| Month | Close | Change |
|---|
| 2025-10 | $2.20 | |
| 2025-11 | $1.84 | -16.4% |
| 2025-12 | $1.34 | -27.2% |
| 2026-01 | $0.81 | -39.8% |
| 2026-02 | $1.08 | +33.9% |
| 2026-03 | $1.00 | -7.4% |
| 2026-04 | $1.00 | -0.3% |
| 2026-05 | $1.17 | +17.4% |
| 2026-06 | $1.03 | -12.0% |
| 2026-07 | $0.93 | -9.7% |
| 2026-08 | $0.91 | -2.3% |
| 2026-09 | $0.89 | -2.5% |
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|
| 2026-09-14 | | |
| 2026-09-14 | | $563M |
| 2026-09-14 | | |
| 2026-09-14 | | $159M |
| 2026-09-14 | $0.20 | $23M |
| 2026-09-14 | | |
Price
| Price | $0.89 |
| Market Cap | $10M |
Financial Health
| Piotroski F-Score | 2 |
| Altman Z-Score | 5.96 |